CAHCardinal Health
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Overbought (RSI 70). Price is +13% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
Moderately shorted, settled Sep 30, 2026, about a week of normal trading to cover. Up 11% since the previous count, up from 3.0% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CAH is trading
Cardinal Health is +64% over the past year while the S&P 500 is +16%: 48 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +13%
vs 200-day average · a clear uptrend
- RSI (14)
- 70
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- 3.1%
Below its 52-week high
Details›
- Last close2026-10-23
- $249.56
- 1 monthS&P 500 −0.94%
- +12%
- 1 yearS&P 500 +16%
- +64%
- 5 yearsS&P 500 +86%
- +465%
- vs 50-day average$236.17
- +5.7%
- 52-week high
- $257.62
- 52-week low
- $155.64
- Annualised volatility
- 27%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
- $60M
| Year | Return |
|---|---|
| 2026 (year to date) | +22% |
| 2025 | +76% |
| 2024 | +19% |
| 2023 | +34% |
| 2022 | +54% |
| 2021 | −0.40% |
| 2020 | +10% |
| 2019 | +18% |
| 2018 | −25% |
| 2017 | −13% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 10 of 10 | +5.4% |
| Feb | 10 | 7 of 10 | +2.8% |
| Mar | 10 | 6 of 10 | −0.15% |
| Apr | 10 | 6 of 10 | −0.73% |
| May | 10 | 5 of 10 | −2.2% |
| Jun | 10 | 6 of 10 | +5.0% |
| Jul | 11 | 6 of 11 | +1.7% |
| Aug | 11 | 4 of 11 | −1.3% |
| Sep | 11 | 3 of 11 | −0.51% |
| Oct | 11 | 5 of 11 | +2.3% |
| Nov | 10 | 8 of 10 | +8.2% |
| Dec | 10 | 3 of 10 | −2.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.
Healthcare
Ranks #79 of 436 by RyuScore